Literature DB >> 2236755

Passive smoking in cystic fibrosis.

H Gilljam1, C Stenlund, A Ericsson-Hollsing, B Strandvik.   

Abstract

The families of 32 children with cystic fibrosis (CF) were interviewed about both their tobacco consumption and their childrens physical activities. Hospital records informed about treatment frequency, lung function and clinical score. Cystic fibrosis families smoked far more than the Swedish average and the passive smokers among our patients seemed to fare less well in all parameters. The children of smoking mothers required significantly longer periods of intravenous antibiotic treatment (P greater than 0.05). Frequent physical exercise seemed to compensate for the potential harmful effects of passive smoking and children with high physical activity living in families who smoked needed significantly less frequent antibiotic treatment than the inactive children (P greater than 0.02). Although this series is small, the results indicate that a smoke-free environment may be important for CF patients. General information is insufficient and extensive psychological support to the families is probably necessary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236755     DOI: 10.1016/s0954-6111(08)80055-8

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research.

Authors:  D G Cook; D P Strachan
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.

Authors:  J Michael Collaco; Lori Vanscoy; Lindsay Bremer; Kathryn McDougal; Scott M Blackman; Amanda Bowers; Kathleen Naughton; Jacky Jennings; Jonathan Ellen; Garry R Cutting
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

3.  Lung function from infancy to school age in cystic fibrosis.

Authors:  C S Beardsmore
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

4.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

Review 5.  The Impact of Air Pollution on the Course of Cystic Fibrosis: A Review.

Authors:  Marion Blayac; Patrice Coll; Valérie Urbach; Pascale Fanen; Ralph Epaud; Sophie Lanone
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

6.  Metabolomics profiling of tobacco exposure in children with cystic fibrosis.

Authors:  Benjamin L Wisniewski; Chandra L Shrestha; Shuzhong Zhang; Rohan Thompson; Myron Gross; Judith A Groner; Karan Uppal; Octavio Ramilo; Asuncion Mejias; Benjamin T Kopp
Journal:  J Cyst Fibros       Date:  2020-05-30       Impact factor: 5.482

Review 7.  The Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: A Review.

Authors:  Benjamin T Kopp; Juan Antonio Ortega-García; S Christy Sadreameli; Jack Wellmerling; Estelle Cormet-Boyaka; Rohan Thompson; Sharon McGrath-Morrow; Judith A Groner
Journal:  Int J Environ Res Public Health       Date:  2016-10-12       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.